{
  "docId": "019de073-3cb6-7521-8cc2-fe64231d84c9",
  "docSlug": "d538949ee3add2afed287b359e626655",
  "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 25 slides",
  "authorId": "an2-therapeutics",
  "authorName": "AN2 Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 25,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "unfair_advantage",
  "function": "other",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "QIDP = Qualified Infectious Disease Product Designation",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-3cb6-7521-8cc2-fe64231d84c9/21",
  "deckHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9",
  "deckJsonHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9.json",
  "deckAnchorHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.75,
        "x": 0.25,
        "y": 0.1
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b766e3ae-b141-4a6e-8f0e-f8b9456a60aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.25,
        "x": 0.28,
        "y": 0.65
      },
      "kind": "list",
      "text": "U.S. Regulatory Exclusivity: Up to 12 years post-marketing (Orphan Drug 7 years, Gain Act 5 years)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e363c4f-7964-4efc-b6bc-ff037330a685",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.6,
        "y": 0.65
      },
      "kind": "list",
      "text": "Europe provides 10 years of exclusivity from launch with centralized filing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5663b3af-2bf3-4e72-aaa2-dd7d84ea445a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.78,
        "y": 0.65
      },
      "kind": "list",
      "text": "Similar mechanisms available in Japan",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a658b4cc-ed9f-4335-94bc-b1408d6dbb5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.28,
        "y": 0.25
      },
      "kind": "list",
      "text": "Composition of Matter (COM) patent expires June 2028; Up to 4-5 years of extensions; Protection up to ~June 2033",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecc2fc55-e98f-4ab1-8173-747531456da3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.28,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "QIDP = Qualified Infectious Disease Product Designation",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cdbb191-eb4f-46e8-b012-40cd95ee7585",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.25,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Intellectual property: ≥ Up to 12 years of exclusivity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eea83695-724f-4284-96ff-aa8700ea5e95",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Authority citation",
      "slug": "authority-citation",
      "agent": null,
      "layer": "slide",
      "matchId": "69c3b563-3b32-41b3-8645-5818d9ea391d",
      "evidence": "source-note: 1. Wu ML, Aziz DB, Dartois V, Dick T. NTM drug discovery: status, gaps and the way forward. Drug Discov Today. 2018;23(8):1502-1519. 2. Spero Therapeutics. 3. Redhill Biopharma.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 19,
      "beatId": "397f2f22-31e1-4ec6-8a66-a5d5f79bbcd3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "Slides 19-22 present the business model, including market opportunity, target product profile, and intellectual property",
      "position": 3,
      "confidence": 0.9,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}